Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
6.5 Autologous kidney-on-chip OoC technology has also been applied to model the kidney, a key organ of the excretory system that regulates fluid balance, electrolyte homeostasis, and the elimination of metabolic waste
Evidence suggests that sustained weight loss maintenance is achievable but requires ongoing effort and often multifaceted approaches
This innovative approach could significantly reduce greenhouse gas emissions and chemical waste associated with traditional pharmaceutical manufacturing methods
PLoS One 2009
Currently, GLP-1R agonists are approved by the US Food and Drug Administration (FDA) to treat type 2 diabetes mellitus (T2D) and weight loss in obesity (Table 1)
US$ 20.75
US$ 24.56
US$ 25.99
US$ 20.54
US$ 26.46
US$ 23.28
US$ 22.21
US$ 22.92
